Clinical Trial: RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pancreatic Cancer Metastatic
Study Type: OBSERVATIONAL
Official Title: Real-world Evidence on Patients With Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Long-term Survival After Treatment With Liposomal Irinotecan (NALLONG)
Brief Summary:
The objective is to describe mPDAC patients still alive one year after the first cycle of nal-IRI
Read more